Navigation Links
Diabetes drug supported by Mexican Diabetes Federation

VANCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Biotech Holdings reports that the Mexican Diabetes Federation has given Biotech's "Sucanon" diabetes drug its support in an overview of diabetic drugs published in the May-June 2007 issue of Diabetes Hoy, the Diabetic Federation's scientific and medical magazine for doctors and other health professionals.

The overview of diabetic drugs, written by Dr. Roberto Cepeda Gonzalez, Medical Director of the Specialized Center for Diabetes, in Mexico City, notes that Sucanon falls in a category of diabetic drugs known as "insulin sensitizers" for their action in making the body's cells more sensitive to circulating insulin. The review (see Endorsements at http://www.sucanonhealth.com/section.asp?pageid=4107) notes that the most widely used insulin sensitizers belong to a family of drugs known as thiazolidinediones or glitazones.

The glitazone drugs, the review notes, have a history of problems in contrast with Sucanon which, clinical studies have indicated, is very safe. The review notes that Sucanon does not have any of the hepatotoxicity or liver-damage risks of the glitazone drugs. The first glitazone, troglitazone was approved in 1998 but was withdrawn shortly thereafter. Two additional glitazones - rosiglitazone and pioglitazone - have recently been targeted with a "black box" warning by the U.S. FDA due to concerns related to cardiac risk when taking these drugs (see http://www.msnbc.msn.com/id/19090626/).

The review in Diabetes Hoy also notes that another widely used Type II Diabetes medication, metformin, presents risks for patients with compromised kidney function, frequently a symptom of Type II Diabetes.

Sucanon, which received regulatory approval in Mexico in 2004, is widely sold
'"/>




Page: 1 2 3

Related medicine technology :

1. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
5. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
10. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
11. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diabetes drug supported Mexican Diabetes Federation
(Date:12/2/2009)... , LUND, Sweden, December 2 /PRNewswire...ent dermatology and wound healing company "Pergamu... promising results from a,clinical Phase I/IIa stu...l,peptide (AMP) treatment for atopic dermatitis. A...sease where dry skin and the skin,s weakened barri...
(Date:12/2/2009)..., HAIFA, Isreal, December 2 /PRNewswire-Firs...SL.OB), a leading developer of advanced,cardiovasc...company,s Board,of Directors approved a one-for-th...vidend, payable to Cardio Vascular Medical Device ... in due course the estimated date the stock,split ...
(Date:12/2/2009)...IRMINGHAM, Ala., Dec. 2 Adults a...sed with cancer. For adults 65 and over, the odds ...s of a man developing prostate cancer are one in s...e one in nine. Vision loss threatens the overall ...njuries, depression and inability to complete dail...
Breaking Medicine Technology:Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Brain Imaging Study Sheds Light on Fibromyalgia 49502 1Deploying the Power of Music to Save Lives West Africas Most Beloved Singer Raises His Voice to End Malaria 49497 1Deploying the Power of Music to Save Lives West Africas Most Beloved Singer Raises His Voice to End Malaria 49497 2Deploying the Power of Music to Save Lives West Africas Most Beloved Singer Raises His Voice to End Malaria 49497 3MSU lands 242 1 million grant to take part in national autism study 8928 1MSU lands 242 1 million grant to take part in national autism study 8928 2
...RLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Pfizer ann...) Tablets 10 mg provided a,significant 61 percent ...es and metabolic syndrome but without heart diseas...a recurrent stroke or,mini-stroke during the trial...k of major coronary events (death from cardiac cau...
...LY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek,...esentation of,positive Phase 2 clinical data demon...ential for INO-1001 as a preventative agent for,ca...in subjects,with acute ST-elevated myocardial infa...onary intervention. The presentation was,made in a...
Other Medicine Technology:Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 2Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 3Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 4Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 5Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4
(Date:12/2/2009)...g youths are more likely to be advertised in magaz...nks consumed mainly by adults, resulting in dispro...alcohol ads, according to a new study. , Researc...lth, Johns Hopkins Bloomberg School of Public Heal...study -- published in this month,s issue of the ...
(Date:12/2/2009)...oes in the battle against drug abuse, but new rese...study dozens of human disease could claim that ro...be used as a simpler and more convenient animal mo...drugs of abuse on the brain. Their study appears o...y journal. , Andrew Ewing and colleagues note t...
(Date:12/2/2009)...h cholesterol and become obese? The same way as pe... , More importantly, according to two new studie...uit flies use the same molecular mechanisms as hum...l and a key form of stored fat that contributes to...y to learn more about the genetic and biological p...
(Date:12/2/2009)...nd ASML Receive Innovation Awards in October. , ...cember 2, 2009 -- ILS Technology, LLC, an industry...ity, today announced that the company and a promin...for technical innovation to the industry., , , , ...ety of Automation (ISA) named ILS Technology as th...
(Date:12/2/2009).../ -- Holly Potter, vice president, Public Relation...aiser Permanente, received the "PR Team Leader" aw...ational Press Club. ,, PR News, PR People A... professionals who day in and day out are making c...rs of this year,s program set the benchmark for PR...
Breaking Medicine News(10 mins):Health News:Alcohol companies target youths with magazine ads, new study shows 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3
...s studied that, babies born to women with high lev...evelopmental problems as babies exposed to lead fr...ently. In an article in the journal Pediatrics, th...e findings demonstrated that protecting children f...
...ariation of a chicken pox vaccine gave good protec...population, and those with impaired immunity becau... infection caused by the same virus that gives ris...y re-emerge years later to cause shingles. U...
...cising, a good amount of fluids should be taken, i...athletics, water is far better than 'energy' drink... summer there is maximum need for fluids,// hencef...ch seem to promise to help your performance and ba...
...otographs could help detect people who are at high...hey say their technique is cheap enough to be used...kes are caused by brain cell death due to bleeding... with changes to their network of blood vessels - ...
...s at the Hopkins University have observed a high r... appear on standard mammography. They have been co...mammography, which involved the injection of a rad...a. The limitation of this kind of camera is that i...
...to Japanese researchers, genetic abnormalities bou... connected to schizophrenia. Hiroshi Ujike, a lead...hat this result supplies genetic evidence that mar... challenges in the world, affecting roughly one of...
Other Medicine News:Health News:Gene glitches connecting pot with Schizophrenia 2
...olution that's perfectly suited to environments wh...light weight and mobility mean that the system can...e easily mounted on a wall. And excessive cable "s... the optional unique MultiMed pod that convenientl...
...oom., ,The Aestiva/5 Induction offers innovative ...Induction has similar user interface as other Aest... for clinicians to use. The new machines enhanced ...alarm, N2O cutoff (with O2 supply failure), O2 flu...
..., ,The Aestiva/5 Compact is an advanced anesthesi...rate price. While maintaining the industry leading...pen architecture, integrated breathing circuit, co...of Datex-Ohmeda's newest ventilation platform, the...
...ent care., ,S/5 Anesthesia Delivery Unit (ADU) is... part of the S/5 Anesthesia System, it combines en...lled gas delivery and agent vaporization with pati...e a truly integrated system. The S/5 ADUs electron...
Medicine Products: